Assessment of the efficacy of aerosolized antibody-based therapies for respiratory diseases in relevant preclinical models.

We are pleased to announce that  Cynbiose and Cynbiose Respiratory will present their combined expertise at the 8^th edition of the Antibody Industrial Symposium, November 23 – 26^th, 2020.

“Assessment of the efficacy of aerosolized antibody-based therapies for respiratory diseases in relevant preclinical models”. Dalloneau E, Confais J, Contamin H.